The latest numbers from the World Health Organization (WHO) report that obesity affects Results of a phase 3 clinical trial recently published in The New England Journal of Medicine demonstrate Top-line results from this phase 3 clinical trial had originally been reported in April 2024 and found tirzepatide helps reduce symptom severity by almost two-thirds in adults with obesity and obstructive sleep apnea
Cons Requires a needle
Eating disorder, suicidal OR homicidal thoughts, cancer with a 5-year remission rule, pancreatitis, warfarin, QT prolongation, Stage 3A+ kidney disease, and a combined thyroid cyst/nodule/cancer/MTC/MEN-2 screen
Being overweight or obese is a major risk factor for poor diabetes control, thus losing weight may assist improve insulin sensitivity and overall diabetes management
Yes, you can absolutely eat at restaurants while taking Ozempic, Wegovy, Mounjaro, or Zepbound